臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"shih j y"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 761-810 / 1137 (共23頁)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-05-26T09:27:12Z	Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations	CHIH-HSIN YANG; Yu C.-J; Lee J.-H; Hsu Y.-C; Chang Y.-L; Shih J.-Y; Yang P.-C.; Wu S.-G;Chih-Hsin Yang;Yu C.-J;Lee J.-H;Hsu Y.-C;Chang Y.-L;Shih J.-Y;Yang P.-C.; Wu S.-G
臺大學術典藏	2020-05-26T09:27:12Z	Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations	Wu J.-Y;Shih J.-Y;Chen K.-Y;Chih-Hsin Yang;Yu C.-J;Yang P.-C.; Wu J.-Y; Shih J.-Y; Chen K.-Y; CHIH-HSIN YANG; Yu C.-J; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:12Z	Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer	Wu J.-Y;Yu C.-J;Chang Y.-C;Chih-Hsin Yang;Shih J.-Y;Yang P.-C.; Wu J.-Y; Yu C.-J; Chang Y.-C; CHIH-HSIN YANG; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:11Z	Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed	Chen C.-Y;Chang Y.-L;Shih J.-Y;Lin J.-W;Chen K.-Y;Chih-Hsin Yang;Yu C.-J;Yang P.-C.; Chen C.-Y; Chang Y.-L; Shih J.-Y; Lin J.-W; Chen K.-Y; CHIH-HSIN YANG; Yu C.-J; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:10Z	EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR	Yang P.-C.;Chih-Hsin Yang;Yu C.-J;Tsai M.-F;Chen Y.-H;Shih J.-Y;Chang Y.-L;Kuo Y.-W;Wu S.-G; Wu S.-G; Kuo Y.-W; Chang Y.-L; Shih J.-Y; Chen Y.-H; Tsai M.-F; Yu C.-J; CHIH-HSIN YANG; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:09Z	Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum	Yu C.-J.;Chen Y.-M;Chih-Hsin Yang;Cheng Y.-K;Chang G.-C;Shih J.-Y;Liao W.-Y; Liao W.-Y; Shih J.-Y; Chang G.-C; Cheng Y.-K; CHIH-HSIN YANG; Chen Y.-M; Yu C.-J.
臺大學術典藏	2020-05-26T09:27:08Z	Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer	Li K.-C; Kuo M.-L; CHIH-HSIN YANG; Chan W.-K; Ho B.-C; Chang G.-C; Shih J.-Y; Yu S.-L; Yang P.-C.; Yang P.-C.;Yu S.-L;Shih J.-Y;Chang G.-C;Ho B.-C;Chan W.-K;Chih-Hsin Yang;Kuo M.-L;Li K.-C;Chen H.-Y;Su K.-Y; Su K.-Y; Chen H.-Y
臺大學術典藏	2020-05-26T09:27:07Z	Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR	Yang P.-C.;Shih J.-Y;Wei P.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Wu S.-G;Chung K.-P; Chung K.-P; Wu S.-G; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Wei P.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:07Z	Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors	Yang P.-C.;Yu C.-J;Chih-Hsin Yang;Ho C.-C;Shih J.-Y;Chen K.-Y;Hsu C.-L; Hsu C.-L; Chen K.-Y; Shih J.-Y; Ho C.-C; CHIH-HSIN YANG; Yu C.-J; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:07Z	Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): A phase 2 trial	Miller V.A.;Yang P.-C;Lorence R.M;Cong X.J;Shahidi M;Dudek A.Z;Sequist L.V;Ho C.-L;Chang G.-C;Yu C.-J;Ou S.H.I;Tsai C.-M;Hsia T.-C;Su W.-C;Shih J.-Y;Chih-Hsin Yang; CHIH-HSIN YANG; Shih J.-Y; Su W.-C; Hsia T.-C; Tsai C.-M; Ou S.H.I; Yu C.-J; Chang G.-C; Ho C.-L; Sequist L.V; Dudek A.Z; Shahidi M; Cong X.J; Lorence R.M; Yang P.-C; Miller V.A.
臺大學術典藏	2020-05-26T09:27:04Z	ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors	Huang C.-P;Tsai M.-F;Chang T.-H;Tang W.-C;Chen S.-Y;Lai H.-H;Lin T.-Y;Chih-Hsin Yang;Yang P.-C;Shih J.-Y;Lin S.-B.; Huang C.-P; Tsai M.-F; Chang T.-H; Tang W.-C; Chen S.-Y; Lai H.-H; Lin T.-Y; CHIH-HSIN YANG; Yang P.-C; Shih J.-Y; Lin S.-B.
臺大學術典藏	2020-05-26T09:27:03Z	Survival of lung adenocarcinoma patients with malignant pleural effusion	Wu S.-G;Yu C.-J;Tsai M.-F;Liao W.-Y;Chih-Hsin Yang;Jan I.-S;Yang P.-C;Shih J.-Y.; Wu S.-G; Yu C.-J; Tsai M.-F; Liao W.-Y; CHIH-HSIN YANG; Jan I.-S; Yang P.-C; Shih J.-Y.
臺大學術典藏	2020-05-26T09:27:02Z	Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer	Liao W.-Y;Chen J.-H;Wu M;Shih J.-Y;Chen K.-Y;Ho C.-C;Chih-Hsin Yang;Yu C.-J.; Liao W.-Y; Chen J.-H; Wu M; Shih J.-Y; Chen K.-Y; Ho C.-C; CHIH-HSIN YANG; Yu C.-J.
臺大學術典藏	2020-05-26T09:27:00Z	Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer	Lee J.-H; Lin Y.-L; Hsu W.-H; Chen H.-Y; Chang Y.-C; Yu C.-J; Shih J.-Y; Lin C.-C; Chen K.-Y; Ho C.-C; Laio W.-Y; Yang P.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:00Z	Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy	Tsai T.-H;Yang C.-Y;Ho C.-C;Liao W.-Y;Jan I.-S;Chen K.-Y;Wang J.-Y;Ruan S.-Y;Yu C.-J;Chih-Hsin Yang;Yang P.-C;Shih J.-Y.; Tsai T.-H; Yang C.-Y; Ho C.-C; Liao W.-Y; Jan I.-S; Chen K.-Y; Wang J.-Y; Ruan S.-Y; Yu C.-J; CHIH-HSIN YANG; Yang P.-C; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:59Z	Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations	Chen Y.-F;Hsieh M.-S;Wu S.-G;Chang Y.-L;Shih J.-Y;Liu Y.-N;Tsai M.-F;Tsai T.-H;Yu C.-J;Chih-Hsin Yang;Yang P.-C.; Chen Y.-F; Hsieh M.-S; Wu S.-G; Chang Y.-L; Shih J.-Y; Liu Y.-N; Tsai M.-F; Tsai T.-H; Yu C.-J; CHIH-HSIN YANG; Yang P.-C.
臺大學術典藏	2020-05-26T09:26:57Z	Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer	Yang P.-C.; Shih J.-Y; Wu S.-G; Yu C.-J; CHIH-HSIN YANG; Wang Y.-F; Lin Y.-T; Lin Y.-T;Wang Y.-F;Chih-Hsin Yang;Yu C.-J;Wu S.-G;Shih J.-Y;Yang P.-C.
臺大學術典藏	2020-05-26T09:26:56Z	IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer	Shih J.-Y.;Chih-Hsin Yang;Yu S.-L;Chen H.-Y;Tsai T.-H;Wu S.-G;Tsai M.-F;Chang T.-H;Liu Y.-N; Liu Y.-N; Chang T.-H; Tsai M.-F; Wu S.-G; Tsai T.-H; Chen H.-Y; Yu S.-L; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:55Z	Treating patients with ALK-positive non-small cell lung cancer: Latest evidence and management strategy	Chih-Hsin Yang;Shih J.Y;Lin C.C;Liao B.C; Liao B.C; Lin C.C; Shih J.Y; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:55Z	Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis	Yang P.-C.;Yu C.-J;Chih-Hsin Yang;Shih J.-Y;Chen K.-Y;Chen J.-H;Hsu C.-L; Hsu C.-L; Chen J.-H; Chen K.-Y; Shih J.-Y; CHIH-HSIN YANG; Yu C.-J; Yang P.-C.
臺大學術典藏	2020-05-26T09:26:53Z	Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion	Shih J.-Y.;Chih-Hsin Yang;Yu C.-J;Hsieh M.-S;Wu S.-G;Tsai T.-H; Tsai T.-H; Wu S.-G; Hsieh M.-S; Yu C.-J; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:52Z	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis	Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Ho C.-C;Chang C.-H;Chen Y.-F;Lin C.-C;Lee J.-H;Liao B.-C; Liao B.-C; Lee J.-H; Lin C.-C; Chen Y.-F; Chang C.-H; Ho C.-C; Shih J.-Y; Yu C.-J; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:52Z	Rapid Response to Sunitinib in a Patient with Lung Adenocarcinoma Harboring KIF5B-RET Fusion Gene	CHIH-HSIN YANG; Shih J.-Y; Wu H; Chih-Hsin Yang;Shih J.-Y;Wu H
臺大學術典藏	2020-05-26T09:26:51Z	The response, outcome and toxicity of aggressive palliative thoracic radiotherapy for metastatic non-small cell lung cancer patients with controlled extrathoracic diseases	Kuo S.-H.;Cheng A.-L;Lan K.-H;Lin Z.-Z;Shih J.-Y;Chen Y.-H;Hsu F.-M;Chih-Hsin Yang;Chiang Y; Chiang Y; CHIH-HSIN YANG; Hsu F.-M; Chen Y.-H; Shih J.-Y; Lin Z.-Z; Lan K.-H; Cheng A.-L; Kuo S.-H.
臺大學術典藏	2020-05-26T09:26:50Z	Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations	Shih J.-Y.;Yang P.-C;Chih-Hsin Yang;Yu C.-J;Chang Y.-L;Wu S.-G;Hsieh M.-S;Chen Y.-F; Chen Y.-F; Hsieh M.-S; Wu S.-G; Chang Y.-L; Yu C.-J; CHIH-HSIN YANG; Yang P.-C; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:48Z	The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients	Shih J.-Y.;Wen Y.-F;Chih-Hsin Yang;Yang P.-C;Yu C.-J;Chang Y.-L;Tsai M.-F;Liu Y.-N;Wu S-G; Wu S-G; Liu Y.-N; Tsai M.-F; Chang Y.-L; Yu C.-J; Yang P.-C; CHIH-HSIN YANG; Wen Y.-F; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:47Z	Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis	Yang P.-C.;Rosell R;Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Ho C.-C;Yu K.-L;Liao W.-Y;Su K.-Y;Ruan S.-Y;Molina-Vila M.A;Chen L.-Y; Chen L.-Y; Molina-Vila M.A; Ruan S.-Y; Su K.-Y; Liao W.-Y; Yu K.-L; Ho C.-C; Shih J.-Y; Yu C.-J; CHIH-HSIN YANG; Rosell R; Yang P.-C.
臺大學術典藏	2020-05-26T09:26:47Z	151P: Outcomes of research biopsies in clinical trials of EGFR mutation-positive NSCLC patients pretreated with EGFR-TKIs	Chih-Hsin Yang;Yu C.-J;Chang Y.-C;Shih J.-Y;Ho C.-C;Lee Y.-F;Lin S.-Y;Lin C.-C;Bai Y.-Y;Liao B.-C; Liao B.-C; Bai Y.-Y; Lin C.-C; Lin S.-Y; Lee Y.-F; Ho C.-C; Shih J.-Y; Chang Y.-C; Yu C.-J; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:44Z	Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non?�Small-Cell Lung Cancer: Analysis and Literature Review	Shih J.-Y.;Chih-Hsin Yang;Yu C.-J;Lin Y.-T; Lin Y.-T; Yu C.-J; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:39Z	Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib	Shih J.-Y; Yu C.-J; Chih-Hsin CHIH-HSIN YANG; Lin C.-A; Liao W.-Y; Ho C.-C; Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Lin C.-A;Liao W.-Y;Ho C.-C
臺大學術典藏	2020-05-26T09:26:38Z	Targeting RET in patients with RET-rearranged lung cancers: Results from the global, multicenter RET registry	Mok T.S.K; CHIH-HSIN YANG; Ou S.-H.I; Pall G; Froesch P; Zalcman G; Gandara D.R; Riess J.W; Velcheti V; Zeidler K; Diebold J; Früh M; Michels S; Monnet I; Popat S; Rosell R; Karachaliou N; Rothschild S.I; Shih J.-Y; Warth A; Muley T; Cabillic F; Mazières J; Drilon A.; Gautschi O;Milia J;Filleron T;Wolf J;Carbone D.P;Owen D;Camidge R;Narayanan V;Doebele R.C;Besse B;Remon-Masip J;Janne P.A;Awad M.M;Peled N;Byoung C.-C;Karp D.D;Van Den Heuvel M;Wakelee H.A;Neal J.W;Mok T.S.K;Chih-Hsin Yang;Ou S.-H.I;Pall G;Froesch P;Zalcman G;Gandara D.R;Riess J.W;Velcheti V;Zeidler K;Diebold J;Fr?h M;Michels S;Monnet I;Popat S;Rosell R;Karachaliou N;Rothschild S.I;Shih J.-Y;Warth A;Muley T;Cabillic F;Mazi?res J;Drilon A.; Gautschi O; Milia J; Filleron T; Wolf J; Carbone D.P; Owen D; Camidge R; Narayanan V; Doebele R.C; Besse B; Remon-Masip J; Janne P.A; Awad M.M; Peled N; Byoung C.-C; Karp D.D; Van Den Heuvel M; Wakelee H.A; Neal J.W
臺大學術典藏	2020-05-26T09:26:37Z	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non?�Small-cell Lung Cancer	Shih J.-Y.;Chih-Hsin Yang;Wu S.-G;Liu Y.-N;Lin Y.-T; Lin Y.-T; Liu Y.-N; Wu S.-G; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:36Z	Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib	Yu C.-J.;Chih-Hsin Yang;Lin C.-C;Lin Z.-Z;Chen J.-S;Shih J.-Y;Chen K.-Y;Ho C.-C;Liao W.-Y;Yao Z.-H; Yao Z.-H; Liao W.-Y; Ho C.-C; Chen K.-Y; Shih J.-Y; Chen J.-S; Lin Z.-Z; Lin C.-C; CHIH-HSIN YANG; Yu C.-J.
臺大學術典藏	2020-05-26T09:26:34Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	Yu C.-J.;Chih-Hsin Yang;Shih J.-Y;Lin C.-C;Lee J.-H;Chang Y.-L;Su K.-Y;Hsu W.-H;Hsu C.-L;Tsai T.-H;Chen K.-Y;Liao W.-Y;Ho C.-C;Liao B.-C;Yang C.-Y;Lin S.-Y; Lin S.-Y; Yang C.-Y; Liao B.-C; Ho C.-C; Liao W.-Y; Chen K.-Y; Tsai T.-H; Hsu C.-L; Hsu W.-H; Su K.-Y; Chang Y.-L; Lee J.-H; Lin C.-C; Shih J.-Y; CHIH-HSIN YANG; Yu C.-J.
臺大學術典藏	2020-05-26T09:26:31Z	Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study	Chih-Hsin Yang;Thress K.S;Huang D.D.-R;Bai Y.-Y;Chang Y.-L;Hsieh M.-S;Su K.-Y;Tsai T.-H;Lee J.-H;Liao W.-Y;Ho C.-C;Yu C.-J;Shih J.-Y;Lin C.-C; Lin C.-C; Shih J.-Y; Yu C.-J; Ho C.-C; Liao W.-Y; Lee J.-H; Tsai T.-H; Su K.-Y; Hsieh M.-S; Chang Y.-L; Bai Y.-Y; Huang D.D.-R; Thress K.S; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:29Z	Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors	Yang P.-C.;Chih-Hsin Chih-Hsin Yang;Yu C.-J;Chang Y.-C;Shih J.-Y;Ho C.-C;Lee Y.-F;Lin S.-Y;Lin C.-C;Lee J.-H;Bai Y.-Y;Liao B.-C; Liao B.-C; Bai Y.-Y; Lee J.-H; Lin C.-C; Lin S.-Y; Lee Y.-F; Ho C.-C; Shih J.-Y; Chang Y.-C; Yu C.-J; Chih-Hsin CHIH-HSIN YANG; Yang P.-C.
臺大學術典藏	2020-05-26T09:26:28Z	Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non?�Small-cell Lung Cancer Patients	Wu T.-H; Hsiue E.H.-C; Lee J.-H; Lin C.-C; Liao W.-Y; Ho C.-C; Shih J.-Y; Yu C.-J; CHIH-HSIN YANG; Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Ho C.-C;Liao W.-Y;Lin C.-C;Lee J.-H;Hsiue E.H.-C;Wu T.-H
臺大學術典藏	2020-05-26T09:26:27Z	Enhancer remodeling and MicroRNA alterations are associated with acquired resistance to ALK inhibitors	Kim S.K; Lee J.M; Lee Y.W; Choi J.W; Kim H.R; Hong M.H; Haam K; Huh N; Kim J.-H; Kim Y.S; Shim H.S; Soo R.A; Shih J.-Y; Chih-Hsin CHIH-HSIN YANG; Kim M; Cho B.C.; Cho B.C.;Kim M;Chih-Hsin Chih-Hsin Yang;Shih J.-Y;Soo R.A;Shim H.S;Kim Y.S;Kim J.-H;Huh N;Haam K;Hong M.H;Kim H.R;Choi J.W;Lee Y.W;Lee J.M;Kim S.K;Pyo K.-H;Choi H.M;Kim S.-K;Lim S.M;Yun M.R; Yun M.R; Lim S.M; Kim S.-K; Choi H.M; Pyo K.-H
臺大學術典藏	2020-05-26T09:26:26Z	Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion	Shih J.-Y.;Chih-Hsin Yang;Yu C.-J;Liu Y.-N;Wu S.-G; Wu S.-G; Liu Y.-N; Yu C.-J; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:24Z	Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation?�Positive Advanced NSCLC: Findings From a Global Named Patient Use Program	Chang G.-C.;Cseh A;Carri?re P;Lorence R.M;Chih-Hsin Chih-Hsin Yang;Unk M;Spataro V;Gautschi O;Liao W.-Y;Shih J.-Y;Nechushtan H;Curioni-Fontecedro A;Peters S; Peters S; Curioni-Fontecedro A; Nechushtan H; Shih J.-Y; Liao W.-Y; Gautschi O; Spataro V; Unk M; Chih-Hsin CHIH-HSIN YANG; Lorence R.M; Carrière P; Cseh A; Chang G.-C.
臺大學術典藏	2020-05-26T09:26:20Z	Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations	Lin Y.-T;Chen J.-S;Liao W.-Y;Ho C.-C;Hsu C.-L;Yang C.-Y;Chen K.-Y;Lee J.-H;Lin Z.-Z;Shih J.-Y;Chih-Hsin Yang;Yu C.-J.; Lin Y.-T; Chen J.-S; Liao W.-Y; Ho C.-C; Hsu C.-L; Yang C.-Y; Chen K.-Y; Lee J.-H; Lin Z.-Z; Shih J.-Y; CHIH-HSIN YANG; Yu C.-J.
臺大學術典藏	2020-05-26T09:26:19Z	Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non?�small-cell lung cancer patients	Yao Z.-H;Liao W.-Y;Ho C.-C;Chen K.-Y;Shih J.-Y;Chen J.-S;Lin Z.-Z;Lin C.-C;Chih-Hsin Yang;Yu C.-J.; Yao Z.-H; Liao W.-Y; Ho C.-C; Chen K.-Y; Shih J.-Y; Chen J.-S; Lin Z.-Z; Lin C.-C; CHIH-HSIN YANG; Yu C.-J.
臺大學術典藏	2020-05-26T09:26:19Z	Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations	Ko J.-C; CHIH-HSIN YANG; Shih J.-Y.; Liang S.-K; Liang S.-K;Ko J.-C;Chih-Hsin Yang;Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:18Z	Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors	Lee J.-H;Chen H.-Y;Hsu F.-M;Chen J.-S;Liao W.-Y;Shih J.-Y;Yu C.-J;Chen K.-Y;Tsai T.-H;Chih-Hsin Yang; Lee J.-H; Chen H.-Y; Hsu F.-M; Chen J.-S; Liao W.-Y; Shih J.-Y; Yu C.-J; Chen K.-Y; Tsai T.-H; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:17Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Yang C.-Y;Liao W.-Y;Ho C.-C;Chen K.-Y;Tsai T.-H;Hsu C.-L;Su K.-Y;Chang Y.-L;Wu C.-T;Hsu C.-C;Liao B.-C;Hsu W.-H;Lee J.-H;Lin C.-C;Shih J.-Y;Chih-Hsin Yang;Yu C.-J.; Yang C.-Y; Liao W.-Y; Ho C.-C; Chen K.-Y; Tsai T.-H; Hsu C.-L; Su K.-Y; Chang Y.-L; Wu C.-T; Hsu C.-C; Liao B.-C; Hsu W.-H; Lee J.-H; Lin C.-C; Shih J.-Y; CHIH-HSIN YANG; Yu C.-J.
臺大學術典藏	2020-05-25T07:35:30Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	Hsu C; Kuo S.-H; Hu F.-C; Cheng A.-L; Shih J.-Y; Yu C.-J; Chia-Chi Lin; Huang T.-C; Yang P.-C; Yang C.-H.
臺大學術典藏	2020-05-25T07:35:28Z	Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors	Chia-Chi Lin; Hsu H.-H; Sun C.-T; Shih J.-Y; Lin Z.-Z; Yu C.-J; Chen G.G; Hsin M.K.Y; Lam K.C; Leung L; Yang C.-H; Mok T.
臺大學術典藏	2020-05-25T07:35:19Z	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis	Yang J.C.-H.; Yu C.-J; Shih J.-Y; Ho C.-C; Chang C.-H; Chen Y.-F; Chia-Chi Lin; Lee J.-H; Liao B.-C
臺大學術典藏	2020-05-25T07:35:18Z	151P: Outcomes of research biopsies in clinical trials of EGFR mutation-positive NSCLC patients pretreated with EGFR-TKIs	Liao B.-C; Bai Y.-Y; Chia-Chi Lin; Lin S.-Y; Lee Y.-F; Ho C.-C; Shih J.-Y; Chang Y.-C; Yu C.-J; Yang J.
臺大學術典藏	2020-05-25T07:35:15Z	Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib	Ho C.-C; Chen K.-Y; Shih J.-Y; Chen J.-S; Lin Z.-Z; Chia-Chi Lin; Yang J.C.H; Yu C.-J.; Yao Z.-H; Liao W.-Y

顯示項目 761-810 / 1137 (共23頁)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52849221 線上人數 : 668 教育部委託研究計畫計畫執行:國立臺灣大學圖書館